Celecoxib
Celecoxib is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Celecoxib; Generic name: CELECOXIB; Drug class: Nonsteroidal Anti-inflammatory Drug [EPC].
| Brand name | Celecoxib |
|---|---|
| Generic name | CELECOXIB |
| Drug class | Nonsteroidal Anti-inflammatory Drug [EPC] |
| Manufacturer | Advanced Rx Pharmacy of Tennessee, LLC |
| Used for | 1. INDICATIONS AND USAGE Celecoxib is indicated Celecoxib is a nonsteroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) ( 1.1 ) Rheumatoid Arthritis (RA) ( 1.2 ) Juvenile Rheumatoid Arthritis (JRA) in patients 2 years and older ( 1.3 ) Ankylosing Spondylitis (AS) ( 1.4 ) Acute Pain (AP) ( 1.5 ) Primary Dysmenorrhea (PD) ( 1.6 ) 1.1 Osteoarthritis(OA) For the management of the signs and symptoms of OA [ see Clinical Studies (14.1) ] 1.2 Rheumatoid Arthritis (RA) For the management of the signs and symptoms of RA [ see Clinical Studies (14.2) ] 1.3 Juvenile Rheumatoid Arthritis (JRA) For the management of the signs and symptoms of JRA in patients 2 years and older [ see Clinical |
| Dosage | 2. DOSAGE AND ADMINISTRATION Use the lowest effective dosage for shortest duration consistent with individual patient treatment goals ( 2.1 ) OA: 200 mg once daily or 100 mg twice daily ( 2.2 , 14.1 ) RA: 100 mg to 200 mg twice daily ( 2.3 , 14.2 ) JRA: 50 mg twice daily in patients 10 kg to 25 kg. 100 mg twice daily in patients more than 25 kg ( 2.4 , 14.3 ) AS: 200 mg once daily single dose or 100 mg twice daily. If no effect is observed after 6 weeks, a trial of 400 mg (single or divided dose |
| Warnings | WARNING: RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS Cardiovascular Thrombotic Events Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction, and stroke, which can be fatal. This risk may occur early in the treatment and may increase with duration of use. [ see Warnings and Precautions (5.1) ] Celecoxib is contraindicated in the setting of coronary artery bypass graft (CABG) surgery. [ see |
| Active ingredient(s) | CELECOXIB |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=15d6ef4f-568d-9d3e-e063-6294a90ab04c |